Indian firm to soon launch copycat of anti-breast-cancer drug For Swiss pharma major Roche, not pursuing an Indian patent for its anti-breast-cancer drug, Herceptin, might mean a loss of millions......
A month ago, Dharmesh Shah had enough time to spare for day-to-day activities of a lesser-known company -- BDR Pharma -- where he serves as chairman & managing director.However, in the last one......
The government's move to issue compulsory licences for three more patented cancer drugs is a jolt to multinational pharmaceutical companies.The plan is to issue CLs for Trastuzumab (or Herceptin,......